ES

Elia Stupka

Managing Director at Angelini Ventures

Singapore

Overview 

Elia Stupka is the Managing Director at Angelini Ventures in Singapore, with a background in Science, Computational Biology, and Bioinformatics. He has held leadership roles at Health Catalyst and has extensive experience in advising and partnering with startups in the life sciences and biotechnology sectors. Stupka's career highlights include serving as the Strategic Advisor, SVP, and General Manager of the Life Sciences Business at Health Catalyst, and being a Venture Partner at First Star Ventures, showcasing his expertise in business development, data analysis, and strategic leadership within the startup ecosystem.

Work Experience 

AV

Angelini Ventures

  • Managing Director

    2021 - Current

    Managing Director at Angelini Ventures, a global healthcare venture fund created by the Angelini Industries group to create, invest and shape the healthcare companies of the future

l

leapcure

  • Strategic Advisor

    2020

Leapcure offers tools for clinical trial patient recruitment, engagement, and retention.

Raised $125,000.00 from 500 Global and 500 Global.

leapcure.com
FS

First Star Ventures

  • Venture Partner

    2019

DT

Duality Technologies

  • Strategic Advisor

    2019

Duality empowers organizations to extract business value from sensitive data by enabling secure data collaborations within their ecosystem.

Raised $50,000,000.00 from Intel Capital, Euclidean Capital, NAventures, Hearst Ventures, Team8 and LG Technology Ventures.

dualitytech.com
EL

Entropica Labs

  • Strategic Advisor

    2018

PI

Pulse Infoframe Inc.

  • Strategic Advisor

    2018

RR

Reboot Rx

  • Strategic Advisor

    2018

Reboot Rx is a nonprofit health tech startup dedicated to fast-tracking the development of affordable cancer treatments.

Raised $1,000,000.00 from Amazon Web Services, The Draper Richards Kaplan Foundation, Lyda Hill and Arnold Ventures.

rebootrx.org
AI

Alkahest, Inc.

  • Scientific Advisory Board Member

    2016

Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline.

Raised $41,000,000.00 from Michael J. Fox Foundation.

alkahest.com
G

Genialis

  • Member Board Of Directors

    2017

  • Strategic Advisor

    2015

    Supporting strategic and business development of Genialis

HL

Healx Ltd

  • Advisor

    2016

Education 

Articles About Elia

Relevant Websites